Fulgent Genetics Shares Outstanding 2015-2025 | FLGT

Fulgent Genetics shares outstanding from 2015 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Fulgent Genetics Annual Shares Outstanding
(Millions of Shares)
2024 30
2023 30
2022 31
2021 31
2020 24
2019 19
2018 18
2017 18
2016 14
2015 12
2014 0
Fulgent Genetics Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 31
2024-12-31 30
2024-09-30 30
2024-06-30 30
2024-03-31 30
2023-12-31 30
2023-09-30 30
2023-06-30 30
2023-03-31 30
2022-12-31 31
2022-09-30 31
2022-06-30 31
2022-03-31 31
2021-12-31 31
2021-09-30 31
2021-06-30 31
2021-03-31 31
2020-12-31 24
2020-09-30 24
2020-06-30 23
2020-03-31 22
2019-12-31 19
2019-09-30 19
2019-06-30 19
2019-03-31 18
2018-12-31 18
2018-09-30 18
2018-06-30 18
2018-03-31 18
2017-12-31 18
2017-09-30 18
2017-06-30 18
2017-03-31 18
2016-12-31 14
2016-09-30 13
2016-06-30 12
2016-03-31 12
2015-12-31
2015-09-30
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.626B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.151B 48.75
Hims & Hers Health (HIMS) United States $11.939B 124.05
Tempus AI (TEM) United States $9.210B 0.00
IRhythm Technologies (IRTC) United States $4.513B 0.00
Inspire Medical Systems (INSP) United States $4.137B 64.64
Privia Health (PRVA) United States $2.813B 192.25
Enovis (ENOV) United States $1.861B 10.37
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.579B 0.00
Phreesia (PHR) United States $1.385B 0.00
Omnicell (OMCL) United States $1.376B 24.27
Azenta (AZTA) United States $1.241B 57.66
10x Genomics (TXG) United States $1.091B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Talkspace (TALK) United States $0.495B 148.00
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.438B 0.00
Standard BioTools (LAB) United States $0.414B 0.00
TruBridge (TBRG) United States $0.358B 793.33
Outset Medical (OM) United States $0.346B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
Health Catalyst (HCAT) United States $0.256B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.132B 0.00
Pulmonx (LUNG) United States $0.119B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00